Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research

Objective: Based on real-world research, we aimed to evaluate the effectiveness and economy of recombinant human thrombopoietin (rhTPO) and recombinant human interleukin 11 (rhIL-11) in the treatment of cancer therapy induced thrombocytopenia (CTIT).Methods: We retrospectively collected clinical dat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Fa-Min Gong, Fu-Yue Liu, Xue Ma, Song-Tao Ma, Hong-Tao Xiao, Gang Jiang, Ting-Ting Qi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-01-01
coleção:	Frontiers in Pharmacology
Assuntos:	cancer therapy induced thrombocytopenia (CTIT) recombinant human thrombopoietin (rhTPO) recombinant human interleukin-11 (rhIL-11) effectiveness economic evaluation
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1288964/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!